Depressive symptoms and shorter survival in lung cancer: the role of leukocyte telomere length

References

• Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006). The influence of bio-behavioural factors on tumour biology: Pathways and mechanisms. Nature Reviews. Cancer, 6(3), 240–248. https://doi.org/10.1038/nrc1820
   PubMed Web of Science ®Google Scholar
• Blackburn, E. H., Epel, E. S., & Lin, J. (2015). Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science (New York, N.Y.), 350(6265), 1193–1198.
   PubMed Web of Science ®Google Scholar
• Brown, K. W., Levy, A. R., Rosberger, Z., & Edgar, L. (2003). Psychological distress and cancer survival: A Follow‐Up 10 years after diagnosis. Psychosomatic Medicine, 65(4), 636–643.
   PubMed Web of Science ®Google Scholar
• Callahan, C. L., Schwartz, K., Ruterbusch, J. J., Shuch, B., Graubard, B. I., Lan, Q., Cawthon, R., Baccarelli, A. A., Chow, W.-H., Rothman, N., Hofmann, J. N., & Purdue, M. P. (2017). Leukocyte telomere length and renal cell carcinoma survival in two studies. British Journal of Cancer, 117(5), 752–755. https://doi.org/10.1038/bjc.2017.237
   PubMed Web of Science ®Google Scholar
• Carlson, L. E., Angen, M., Cullum, J., Goodey, E., Koopmans, J., Lamont, L., MacRae, J. H., Martin, M., Pelletier, G., Robinson, J., Simpson, J. S. A., Speca, M., Tillotson, L., & Bultz, B. D. (2004). High levels of untreated distress and fatigue in cancer patients. British Journal of Cancer, 90(12), 2297–2304. https://doi.org/10.1038/sj.bjc.6601887
   PubMed Web of Science ®Google Scholar
• Caruso, R., Nanni, M. G., Riba, M., Sabato, S., Mitchell, A., Croce, E., & Grassi, L. (2017). Depressive spectrum disorders in cancer: Prevalence, risk factors and screening for depression: A critical review. Acta Oncologica (Stockholm, Sweden), 56(2), 146–155.
   PubMed Web of Science ®Google Scholar
• Cawthon, R. M. (2002). Telomere measurement by quantitative PCR. Nucleic Acids Research, 30(10), e47. https://doi.org/10.1093/nar/30.10.e47
   PubMed Web of Science ®Google Scholar
• DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160(14), 2101–2107. https://doi.org/10.1001/archinte.160.14.2101
   PubMed Web of Science ®Google Scholar
• Doherty, J. A., Grieshober, L., Houck, J. R., Barnett, M. J., Tapsoba, J. D. D., Thornquist, M., Wang, C.-Y., Goodman, G. E., & Chen, C. (2018). Telomere length and lung cancer mortality among heavy smokers. Cancer Epidemiology, Biomarkers & Prevention, 27(7), 829–837. https://doi.org/10.1158/1055-9965.EPI-17-1183
   PubMed Web of Science ®Google Scholar
• Epel, E. S., Blackburn, E. H., Lin, J., Dhabhar, F. S., Adler, N. E., Morrow, J. D., & Cawthon, R. M. (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences of the United States of America, 101(49), 17312–17315.
   PubMed Web of Science ®Google Scholar
• Fesinmeyer, M. D., Mehta, V., Blough, D., Tock, L., & Ramsey, S. D. (2010). Effect of radiotherapy interruptions on survival in medicare enrollees with local and regional head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics, 78(3), 675–681. https://doi.org/10.1016/j.ijrobp.2009.08.004
   PubMed Web of Science ®Google Scholar
• Field, A. (2013). Discovering statistics using IBM SPSS statistics. Sage.
   Google Scholar
• Gallicchio, L., Gadalla, S. M., Murphy, J. D., & Simonds, N. I. (2018). The effect of cancer treatments on telomere length: A systematic review of the literature. Journal of the National Cancer Institute, 110(10), 1048–1058.
   PubMedGoogle Scholar
• Ganesh, M., Narayanan, G. S., & Kumar, R. (2020). Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment. Reports of Practical Oncology and Radiotherapy: Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology, 25(1), 28–34.
   PubMedGoogle Scholar
• Hann, D., Winter, K., & Jacobsen, P. (1999). Measurement of depressive symptoms in cancer patients: Evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). Journal of Psychosomatic Research, 46(5), 437–443. https://doi.org/10.1016/S0022-3999(99)00004-5
   PubMed Web of Science ®Google Scholar
• Henningfield, M. F., & Adjei, A. A. (2017). Lung cancer awareness month—A lot of progress, but more work needs to be done. Elsevier.
   Google Scholar
• Hopwood, P., & Stephens, R. J. (2000). Depression in patients with lung cancer: Prevalence and risk factors derived from quality-of-life data. Journal of Clinical Oncology, 18(4), 893–893. https://doi.org/10.1200/JCO.2000.18.4.893
   PubMed Web of Science ®Google Scholar
• Ko, A., Kim, K., Son, J. S., Park, H. Y., & Park, S. M. (2019). Association of pre-existing depression with all-cause, cancer-related, and noncancer-related mortality among 5-year cancer survivors: A population-based cohort study. Scientific Reports, 9(1), 1–9. https://doi.org/10.1038/s41598-019-54677-y
   PubMed Web of Science ®Google Scholar
• Kraemer, H. C., & Blasey, C. M. (2004). Centring in regression analyses: A strategy to prevent errors in statistical inference. International Journal of Methods in Psychiatric Research, 13(3), 141–151. https://doi.org/10.1002/mpr.170
   PubMed Web of Science ®Google Scholar
• Kraemer, H. C., Kiernan, M., Essex, M., & Kupfer, D. J. (2008). How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychology, 27(2S), S101–S108.
   PubMedGoogle Scholar
• Kraemer, H. C., Stice, E., Kazdin, A., Offord, D., & Kupfer, D. (2001). How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. American Journal of Psychiatry, 158(6), 848–856. https://doi.org/10.1176/appi.ajp.158.6.848
   PubMed Web of Science ®Google Scholar
• Lee, D. B., Kim, E. S., & Neblett, E. W. (2017). The link between discrimination and telomere length in African American adults. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 36(5), 458–467.
   PubMed Web of Science ®Google Scholar
• Lin, J., Blalock, J. A., Chen, M., Ye, Y., Gu, J., Cohen, L., Cinciripini, P. M., & Wu, X. (2015). Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients. Cancer Epidemiology Biomarkers & Prevention, 24(2), 336–343. https://doi.org/10.1158/1055-9965.EPI-14-0992
   PubMed Web of Science ®Google Scholar
• Lin, J., Cheon, J., Brown, R., Coccia, M., Puterman, E., Aschbacher, K., Sinclair, E., Epel, E., & Blackburn, E. H. (2016). Systematic and cell type-specific telomere length changes in subsets of lymphocytes. Journal of Immunology Research, 2016, 5371050. https://doi.org/10.1155/2016/5371050
   PubMed Web of Science ®Google Scholar
• Linden, W., Vodermaier, A., Mackenzie, R., & Greig, D. (2012). Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age. Journal of Affective Disorders, 141(2–3), 343–351. https://doi.org/10.1016/j.jad.2012.03.025
   PubMed Web of Science ®Google Scholar
• Lin, J., Epel, E., Cheon, J., Kroenke, C., Sinclair, E., Bigos, M., Wolkowitz, O., Mellon, S., & Blackburn, E. (2010). Analyses and comparisons of telomerase activity and telomere length in human T and B cells: Insights for epidemiology of telomere maintenance. Journal of Immunological Methods, 352(1–2), 71–80. https://doi.org/10.1016/j.jim.2009.09.012
   PubMed Web of Science ®Google Scholar
• Lutgendorf, S. K., & Andersen, B. L. (2015). Biobehavioral approaches to cancer progression and survival: Mechanisms and interventions. American Psychologist, 70(2), 186–197. https://doi.org/10.1037/a0035730
   PubMed Web of Science ®Google Scholar
• Ma, H., Zhou, Z., Wei, S., Liu, Z., Pooley, K. A., Dunning, A. M., Svenson, U., Roos, G., Hosgood, H. D., Shen, M., & Wei, Q. (2011). Shortened telomere length is associated with increased risk of cancer: A meta-analysis. PLoS One, 6(6), e20466. https://doi.org/10.1371/journal.pone.0020466
   PubMed Web of Science ®Google Scholar
• Manoliu, A., Bosch, O. G., Brakowski, J., Brühl, A. B., & Seifritz, E. (2018). The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative review. Journal of Affective Disorders, 225, 630–646.
   PubMed Web of Science ®Google Scholar
• Massarelli, E., Papadimitrakopoulou, V., Welsh, J., Tang, C., & Tsao, A. S. (2014). Immunotherapy in lung cancer. Translational Lung Cancer Research, 3(1), 53–63. https://doi.org/10.3978/j.issn.2218-6751.2014.01.01
   PubMedGoogle Scholar
• Massie, M. J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute Monographs, 2004(32), 57–71. https://doi.org/10.1093/jncimonographs/lgh014
   Google Scholar
• McFarland, D. C., Saracino, R. M., Miller, A. H., Breitbart, W., Rosenfeld, B., & Nelson, C. (2020). Prognostic implications of depression and inflammation in patients with metastatic lung cancer. Future Oncology, 17(2), 183–196.
   PubMed Web of Science ®Google Scholar
• Mielgo-Rubio, X., Uribelarrea, E. A., Cortés, L. Q., & Moyano, M. S. (2021). Immunotherapy in non-small cell lung cancer: Update and new insights. Journal of Clinical and Translational Research, 7(1), 1–21.
   PubMedGoogle Scholar
• Needham, B. L., Rehkopf, D., Adler, N., Gregorich, S., Lin, J., Blackburn, E. H., & Epel, E. S. (2015). Leukocyte telomere length and mortality in the National Health and Nutrition Examination Survey, 1999–2002. Epidemiology (Cambridge, Mass.), 26(4), 528–535.
   PubMed Web of Science ®Google Scholar
• Pinquart, M., & Duberstein, P. R. (2010). Depression and cancer mortality: A meta-analysis. Psychological Medicine, 40(11), 1797–1810. https://doi.org/10.1017/S0033291709992285
   PubMed Web of Science ®Google Scholar
• Pirl, W. F., Temel, J. S., Billings, A., Dahlin, C., Jackson, V., Prigerson, H. G., Greer, J., & Lynch, T. J. (2008). Depression after diagnosis of advanced non-small cell lung cancer and survival: A pilot study. Psychosomatics, 49(3), 218–224. https://doi.org/10.1176/appi.psy.49.3.218
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. https://doi.org/10.1177/014662167700100306
   Web of Science ®Google Scholar
• Raison, C. L., & Miller, A. H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry, 54(3), 283–294.
   PubMed Web of Science ®Google Scholar
• Renner, W., Krenn-Pilko, S., Gruber, H., Herrmann, M., & Langsenlehner, T. (2018). Relative telomere length and prostate cancer mortality. Prostate Cancer and Prostatic Diseases, 21(4), 579–583. https://doi.org/10.1038/s41391-018-0068-3
   PubMed Web of Science ®Google Scholar
• Ridout, K. K., Ridout, S. J., Price, L. H., Sen, S., & Tyrka, A. R. (2016). Depression and telomere length: A meta-analysis. Journal of Affective Disorders, 191, 237–247. https://doi.org/10.1016/j.jad.2015.11.052
   PubMed Web of Science ®Google Scholar
• Rivera-Tavarez, C. E. (2017). Can we increase our health span? Physical Medicine and Rehabilitation Clinics of North America, 28(4), 681–692. https://doi.org/10.1016/j.pmr.2017.08.002
   PubMed Web of Science ®Google Scholar
• Rode, L., Nordestgaard, B. G., & Bojesen, S. E. (2015). Peripheral blood leukocyte telomere length and mortality among 64 637 individuals from the general population. Journal of the National Cancer Institute, 107(6), djv074. https://doi.org/10.1093/jnci/djv074
   PubMedGoogle Scholar
• Sanchez-Espiridion, B., Chen, M., Chang, J. Y., Lu, C., Chang, D. W., Roth, J. A., Wu, X., & Gu, J. (2014). Telomere length in peripheral blood leukocytes and lung cancer risk: A large case-control study in Caucasians. Cancer Research, 74(9), 2476–2486. https://doi.org/10.1158/0008-5472.CAN-13-2968
   PubMed Web of Science ®Google Scholar
• Satin, J. R., Linden, W., & Phillips, M. J. (2009). Depression as a predictor of disease progression and mortality in cancer patients. Cancer, 115(22), 5349–5361. https://doi.org/10.1002/cncr.24561
   PubMed Web of Science ®Google Scholar
• Schutte, N. S., & Malouff, J. M. (2015). The association between depression and leukocyte telomere length: A meta‐analysis. Depression and Anxiety, 32(4), 229–238. https://doi.org/10.1002/da.22351
   PubMed Web of Science ®Google Scholar
• Seow, W. J., Cawthon, R. M., Purdue, M. P., Hu, W., Gao, Y.-T., Huang, W.-Y., Weinstein, S. J., Ji, B.-T., Virtamo, J., Hosgood, H. D., Bassig, B. A., Shu, X.-O., Cai, Q., Xiang, Y.-B., Min, S., Chow, W.-H., Berndt, S. I., Kim, C., Lim, U., … Lan, Q. (2014). Telomere length in white blood cell DNA and lung cancer: A pooled analysis of three prospective cohorts. Cancer Research, 74(15), 4090–4098. https://doi.org/10.1158/0008-5472.CAN-14-0459
   PubMed Web of Science ®Google Scholar
• Sephton, S. E., Lush, E., Dedert, E. A., Floyd, A. R., Rebholz, W. N., Dhabhar, F. S., Spiegel, D., & Salmon, P. (2013). Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain, Behavior, and Immunity, 30Suppl, S163–S170. https://doi.org/10.1016/j.bbi.2012.07.019
   Google Scholar
• Sephton, S., & Spiegel, D. (2003). Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease? Brain, Behavior, and Immunity, 17(5), 321–328. https://doi.org/10.1016/s0889-1591(03)00078-3
   PubMed Web of Science ®Google Scholar
• Shao, L., Wood, C. G., Zhang, D., Tannir, N. M., Matin, S., Dinney, C. P., & Wu, X. (2007). Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. Journal of Urology, 178(4), 1492–1496. https://doi.org/10.1016/j.juro.2007.05.112
   PubMed Web of Science ®Google Scholar
• Sharpley, C. F., Christie, D. R., Bitsika, V., Agnew, L. L., Andronicos, N. M., & McMillan, M. E. (2018). Associations between reduced telomere length, depressed mood, anhedonia, and irritability in prostate cancer patients: Further evidence for the presence of “male depression”? Psycho-oncology, 27(3), 1072–1074. https://doi.org/10.1002/pon.4547
   PubMed Web of Science ®Google Scholar
• Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014). Cancer statistics, 2014. CA: A Cancer Journal of Clinicians, 64(1), 9–29. https://doi.org/10.3322/caac.21208
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 66(1), 7–30. https://doi.org/10.3322/caac.21332
   PubMed Web of Science ®Google Scholar
• Siegel, R. L., Miller, K. D., & Jemal, A. (2018). Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68(1), 7–30. https://doi.org/10.3322/caac.21442
   PubMed Web of Science ®Google Scholar
• Spiegel, D., & Giese-Davis, J. (2003). Depression and cancer: Mechanisms and disease progression. Biological Psychiatry, 54(3), 269–282. https://doi.org/10.1016/s0006-3223(03)00566-3
   PubMed Web of Science ®Google Scholar
• Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71(3), 209–249. https://doi.org/10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Valls, C., Piñol, C., Reñé, J., Buenestado, J., & Viñas, J. (2011). Telomere length is a prognostic factor for overall survival in colorectal cancer. Colorectal Disease, 13(11), 1265–1272. https://doi.org/10.1111/j.1463-1318.2010.02433.x
   PubMed Web of Science ®Google Scholar
• Vance, M. C., Bui, E., Hoeppner, S. S., Kovachy, B., Prescott, J., Mischoulon, D., Walton, Z. E., Dong, M., Nadal, M. F., Worthington, J. J., Hoge, E. A., Cassano, P., Orr, E. H., Fava, M., de Vivo, I., Wong, K.-K., & Simon, N. M. (2018). Prospective Association between Major Depressive Disorder and Leukocyte Telomere Length over Two Years. Psychoneuroendocrinology, 90, 157–164. https://doi.org/10.1016/j.psyneuen.2018.02.015
   PubMed Web of Science ®Google Scholar
• Walker, J., Mulick, A., Magill, N., Symeonides, S., Gourley, C., Burke, K., Belot, A., Quartagno, M., van Niekerk, M., Toynbee, M., Frost, C., & Sharpe, M. (2021). Major depression and survival in people with cancer. Psychosomatic Medicine, 83(5), 410–416. https://doi.org/10.1097/PSY.0000000000000942
   PubMedGoogle Scholar
• Wang, Y.-H., Li, J.-Q., Shi, J.-F., Que, J.-Y., Liu, J.-J., Lappin, J. M., Leung, J., Ravindran, A. V., Chen, W.-Q., Qiao, Y.-L., Shi, J., Lu, L., & Bao, Y.-P. (2020). Depression and anxiety in relation to cancer incidence and mortality: A systematic review and meta-analysis of cohort studies. Molecular Psychiatry, 25(7), 1487–1499. https://doi.org/10.1038/s41380-019-0595-x
   PubMed Web of Science ®Google Scholar
• Wang, Q., Zhan, Y., Pedersen, N. L., Fang, F., & Hägg, S. (2018). Telomere length and all-cause mortality: A meta-analysis. Ageing Research Reviews, 48, 11–20.
   PubMed Web of Science ®Google Scholar
• Weischer, M., Nordestgaard, B. G., Cawthon, R. M., Freiberg, J. J., Tybjaerg-Hansen, A., & Bojesen, S. E. (2013). Short telomere length, cancer survival, and cancer risk in 47102 individuals. JNCI: Journal of the National Cancer Institute, 105(7), 459–468. https://doi.org/10.1093/jnci/djt016
   PubMedGoogle Scholar
• Wentzensen, I. M., Mirabello, L., Pfeiffer, R. M., & Savage, S. A. (2011). The association of telomere length and cancer: A meta-analysis. Cancer Epidemiology and Prevention Biomarkers, 20(6), pp.1238–1250.
   Web of Science ®Google Scholar
• Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., Kronenberg, F., & Kiechl, S. (2010). Telomere length and risk of incident cancer and cancer mortality. JAMA, 304(1), 69–75. https://doi.org/10.1001/jama.2010.897
   PubMed Web of Science ®Google Scholar
• Wu, X., Amos, C. I., Zhu, Y., Zhao, H., Grossman, B. H., Shay, J. W., Luo, S., Hong, W. K., & Spitz, M. R. (2003). Telomere dysfunction: A potential cancer predisposition factor. JNCI: Journal of the National Cancer Institute, 95(16), 1211–1218. https://doi.org/10.1093/jnci/djg011
   PubMedGoogle Scholar
• Yang, P., Allen, M. S., Aubry, M. C., Wampfler, J. A., Marks, R. S., Edell, E. S., Thibodeau, S., Adjei, A. A., Jett, J., & Deschamps, C. (2005). Clinical features of 5,628 primary lung cancer patients: Experience at Mayo Clinic from 1997 to 2003. Chest, 128(1), 452–462. https://doi.org/10.1378/chest.128.1.452
   PubMed Web of Science ®Google Scholar
• Zhang, C., Chen, X., Li, L., Zhou, Y., Wang, C., & Hou, S. (2015). The association between telomere length and cancer prognosis: Evidence from a meta-analysis. PLoS One, 10(7), e0133174.
   PubMed Web of Science ®Google Scholar
• Zimmaro, L. A., Sephton, S. E., Siwik, C. J., Phillips, K. M., Rebholz, W. N., Kraemer, H. C., Giese-Davis, J., Wilson, L., Bumpous, J. M., & Cash, E. D. (2018). Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways. Cancer, 124(5), 1053–1060. https://doi.org/10.1002/cncr.31109
   PubMed Web of Science ®Google Scholar